Transcriptional and immune signatures of ESR1 and PIK3CA co-mutations in HR+ MBC
Discovery of distinct immunosuppressive microenvironments to guide combination therapies
INDICATION
Breast
BIOMARKER
ESR1
Differential Gene Expression in PIK3CA-Mutant vs. WT HR+/HER2- Metastatic Breast Cancer

Volcano plot illustrating upregulated and downregulated genes in PIK3CA-mutant tumors compared to wild-type. Key genes with significant expression changes are highlighted.


